BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24832159)

  • 1. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Immunohistochemistry in the Subtyping of Periampullary Adenocarcinoma.
    Bakshi N; Dhawan S; Nundy S; Rao S; Chopra P; Bhalla S
    Int J Surg Pathol; 2019 Sep; 27(6):598-608. PubMed ID: 30942099
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
    Liu F; Shen D; Ma Y; Song Q; Wang H
    J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.
    Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG
    World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
    Kawabata Y; Tanaka T; Nishisaka T; Inao T; Nishi T; Yano S
    Diagn Pathol; 2010 Nov; 5():75. PubMed ID: 21106111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis.
    de Bakker J; Sommeijer D; Besselink M; Kazemier G; van Grieken N
    World J Surg Oncol; 2022 Dec; 20(1):406. PubMed ID: 36566267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
    da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
    J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
    Sree UD; Prayaga AK; R Reddy VV; Rukmanghadha N; Chowhan AK; Phaneendra BV
    Indian J Pathol Microbiol; 2022; 65(1):42-48. PubMed ID: 35074964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
    Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
    Zhou H; Schaefer N; Wolff M; Fischer HP
    Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.
    Reid MD; Balci S; Ohike N; Xue Y; Kim GE; Tajiri T; Memis B; Coban I; Dolgun A; Krasinskas AM; Basturk O; Kooby DA; Sarmiento JM; Maithel SK; El-Rayes BF; Adsay V
    Mod Pathol; 2016 Dec; 29(12):1575-1585. PubMed ID: 27586202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1, CK20, and CDX2 immunohistochemical markers can sub-classify periampullary carcinomas into pancreaticobiliary, intestinal, and mixed subtypes.
    Manohar KM; Sasikala M; Anuradha S; Ramji C; Sashidhar RB; Rao GV; Pradeep R; Reddy DN
    Indian J Pathol Microbiol; 2021; 64(4):693-701. PubMed ID: 34673588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation.
    Ivanovic AM; Alessandrino F; Maksimovic R; Micev M; Ostojic S; Gore RM; Mortele KJ
    AJR Am J Roentgenol; 2017 Mar; 208(3):W71-W78. PubMed ID: 28095024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.